CVS Health will face a new challenge in the coming year: proving to investors it can drive growth and retain customers, even as demand for Covid vaccines and testing fades. Shares fell 5.45% to close Wednesday at $104.79, after the health-care company beat expectations for fiscal fourth-quarter earnings, but declined […]

Open chat
thank you for contacting us, for more information
please chat